NCT/UCC Core Unit for Molecular Tumor Diagnostics
The Core Unit for Molecular Tumor Diagnostics (CMTD) is a research facility for the molecular characterization of sporadic and hereditary tumors based on next generation sequencing (NGS) techniques, bioinformatic analysis pipelines and interpretation of the results by experienced molecular pathologists and human geneticists. It is an essential and fundamental interface in the area of translational cancer research and clinical studies. The aim of the CMTD is the fast translation of novel molecular markers into clinical application by making indication-specific multi gene panels available.
Service features
Project Request
Please fill out our project request form and send it back to:
cmtd-service(at)nct-dresden.de
Please keep the project title short and unique for your project. As project description 2-3 short sentences about your project are sufficient. All other fields are optional, but will help us and you for a better planning of your project.
Applications
Please contact us for consultation prior to sequencing projects. This will allow us to provide initial support in study design and therefore optimize the performance of the NGS experiments.
We offer high-throughput sequencing services, consultation and expert assistance in planning, sample preparation and method development.
Here are a few examples of what we offer:
DNA Panel sequencing- TruSight Oncology (Illumina)
- TruSight Tumor 15 Panel (Illumina)
- Human Comprehensive Cancer Panel (Qiagen)
DNA Panel sequencing (custom)
DNA Exom sequencing
Additional methods
RNA Sequencing Whole Transcriptome
- Illumina stranded total RNA, Ribo-Zero Plus (Illumina)
- SMART-Seq stranded Kit (Takara Bio)
- Ultra Low Input V4 (Takara Bio)
RNA targeted Sequencing
A wide range of next-generation sequencing (NGS) applications are used in a targeted manner to provide comprehensive answers to medical questions.
State-of-the-art high-throughput sequencing is used to study the genetic material of patients and changes in tumors.
Contact
Alexander Krüger
Coordinator Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0)351 458 16857
alexander.krueger(at)nct-dresden.de
cmtd-service(at)nct-dresden.de
Directors
Director of the Institute for Pathology
Co-Director Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0) 351 458 3000
gustavo.baretton(at)ukdd.de
Prof. Dr. Diana Le Duc MD/PhD
Director of the Institute for Clinical Genetics
Co-Director Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0) 351 458 5136
diana.leduc(at)ukdd.de
Medical Coordinator
Prof. Dr. med. Daniela Aust
Head of Molecular Pathology
Tel.: +49 (0)351 458 3004
daniela.aust(at)ukdd.de
Scientific Coordinator
Dr. rer. nat. Doreen William
Head of Molecular Genetic Research of the Institute for Clinical Genetics
Tel.: +49 (0)351 458 13914
Doreen.William(at)ukdd.de
Staff
Mariana Martinez Noriega M.Sc.
Bioinformatician
Tel.: +49 (0)351 458 11327
mariana.martineznoriega(at)nct-dresden.de
Enrico Zyball
Technical Assistant
Tel.: +49 (0)351 458 19621
enrico.zyball(at)nct-dresden.de
